iridium radioisotopes has been researched along with Cancer of Cervix in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (4.30) | 18.7374 |
1990's | 22 (23.66) | 18.2507 |
2000's | 27 (29.03) | 29.6817 |
2010's | 33 (35.48) | 24.3611 |
2020's | 7 (7.53) | 2.80 |
Authors | Studies |
---|---|
Kandasamy, S; Kannan, M; Karunanidhi, G; Neelakandan, V; Ramapandian, S; Sampath, E; Sinnatamby, M | 1 |
Li, J; Luo, J; Wang, B; Wang, P; Wang, X; Wen, A; Yan, C | 1 |
Ikeda, M; Ito, J; Itoh, Y; Kawamura, M; Kikkawa, F; Kozai, Y; Naganawa, S; Nakahara, R; Okada, T | 1 |
Fu, Z; Jiang, C; Jiang, Y; Liu, T; Qin, W; Shi, K; Sun, Q; Wang, F; Wu, P; Ye, Z | 1 |
Chen, Y; Deng, J; Hu, Q; Huang, Y; Li, C; Li, X; Liang, B; Liu, H; Ma, Y; Pu, Y; Su, X; Wang, H; Wang, W; Wu, H; You, J; Zhang, Y | 1 |
Enger, SA; Morcos, M; Viswanathan, AN | 1 |
Han, DY; Mashouf, S; Meigooni, AS; Owrangi, A; Safigholi, H; Soliman, A; Song, WY | 1 |
Álvarez-Romero, JT; Cabrera Vertti, MR; de la Cruz Hernández, D; Gutiérrez Lore, S; Tamayo, JAG; Walwyn Salas, G | 1 |
Gomi, T; Hara, H; Hayakawa, K; Ishiyama, H; Muraishi, H; Nozawa, M; Shimo, T; Shuto, N; Takei, H; Terazaki, T; Watanabe, Y | 1 |
Rongsriyam, K; Tantivatana, T | 1 |
Ben Mrad, M; Chauleur, C; de Laroche, G; Espenel, S; Garcia, MA; Guy, JB; Langrand-Escure, J; Magné, N; Moreno-Acosta, P; Rancoule, C; Trone, JC; Vallard, A | 1 |
Enger, SA; Morcos, M | 1 |
Enger, SA; Keyes, R; Mao, X; Pineau, J | 1 |
Aird, EGA; Bidmead, M; Bownes, P; Díez, P; Eaton, D; Gandon, L; Gouldstone, CA; Lee, CD; Lowe, G; Palmer, AL; Sander, T; Sharpe, PHG; Simnor, T; Thomas, RAS | 1 |
Awunor, OA; Dixon, B; Walker, C | 1 |
Zhang, H; Zhang, WH; Zhu, YL | 1 |
Harima, Y; Ikeda, K; Kanno, S; Komemushi, A; Shiga, T; Tanigawa, N; Utsunomiya, K | 1 |
Choi, D; Devic, S; Han, DY; Ravi, A; Scanderbeg, DJ; Song, B; Song, WY; Webster, MJ; Yashar, C | 1 |
C-M Ma, C; Chibani, O | 1 |
Akiyama, H; Kotsuma, T; Masui, K; Nakamura, S; Narumi, Y; Shimbo, T; Tanaka, E; Uesugi, Y; Yamazaki, H; Yoshida, K; Yoshikawa, N; Yoshioka, Y | 1 |
He, R; Mobit, PN; Packianathan, S; Yang, CC | 1 |
Aguayo, M; Andrés, I; Arenas, M; Berenguer, R; Camacho-Lopez, C; Gascon, M; Rovirosa, A; Sabater, S; Sevillano, M; Villas, MV | 1 |
Li, HP; Li, LY; Luo, B; Pan, M; Shu, KY; Zeng, SY | 1 |
Ahn, SD; Choi, EK; Kim, JH; Kim, YM; Kim, YS; Kim, YT; Lee, SW; Nam, JH; Shin, SS | 1 |
Chang, WC; Chen, SW; Hung, YC; Liang, JA; Lin, FJ; Yang, SN; Yeh, LS | 1 |
Brunaud, C; Métayer, Y; Meyer, P; Peiffert, D | 1 |
Chen, HC; Fang, FM; Hsu, HC; Huang, EY; Huang, YJ; Lan, JH; Wang, CJ; Wang, CY; Wang, YM | 1 |
Andic, F; Garipagaoglu, M; Kizildag, AU; Toy, A; Tuncel, N | 1 |
Anker, CJ; Boucher, KM; Cachoeira, CV; Gaffney, DK; Rankin, J | 1 |
Albuquerque, K; Chi, A; Gao, M; Nguyen, NP; Sinacore, J; Vali, F | 1 |
Guo, WB; Huang, YH; Li, HP; Tan, GS; Xiang, XH; Yang, JY; Yu, L | 1 |
Fujiwara, H; Hashimoto, Y; Ito, K; Kakizawa, H; Kaneyasu, Y; Kenjo, M; Kudo, Y; Murakami, Y; Nagai, N; Nagata, Y; Toyota, N; Yuki, S | 1 |
Eifel, PJ; Gifford, KA; Gillin, MT; Horton, JL; Lawyer, AA; Mourtada, F; Price, MJ | 1 |
Inoue, T; Isohashi, F; Koizumi, M; Konishi, K; Kotsuma, T; Ogata, T; Sumida, I; Suzuki, O; Takahashi, Y; Yoshioka, Y | 1 |
Andersen, CE; Lindegaard, JC; Nielsen, SK; Tanderup, K | 1 |
Eifel, PJ; Kry, SF; Mourtada, F; Price, MJ; Salehpour, M | 1 |
Barillot, I; Baron, MH; Carrère, MO; Castelain, B; Charra-Brunaud, C; Cussac, A; Delannes, M; Haie-Meder, C; Kerr, C; Kirova, Y; Krzisch, C; Lang, P; Lesaunier, F; Maillard, S; Morelle, M; Peiffert, D; Peignaux, K; Pommier, P; Quetin, P; Remonnay, R; Romestaing, P; Thomas, L; Williaume, D | 1 |
Bai, P; Li, W; Ma, Y; Zhang, R | 1 |
Chang, WC; Chen, SW; Hung, YC; Liang, JA; Lin, FJ; Lin, WC; Shiau, AC; Yang, SN; Yeh, LS; Yu, CY | 1 |
Kamada, T; Kato, S; Kiyohara, H; Nakano, T; Ohkubo, Y; Ohno, T; Tran, DN | 1 |
Biagioli, MC; Finkelstein, SE; Saini, AS; Zhang, GG | 1 |
Colussi, VC; Kunos, CA; Oleinick, NL; Pink, J; Radivoyevitch, T | 1 |
Coalter, G; Haughey, A; Mugabe, K | 1 |
Jiang, W; Li, L; Liu, Y; Wu, YY; Zeng, SY; Zhong, ML | 1 |
Kodaira, T; Mitsumori, M; Numasaki, H; Shinoda, A; Teshima, T; Toita, T; Tomita, N; Uno, T | 1 |
Ke, QH; Liu, Z; Su, XY; Yang, JY; Zhang, WT; Zhou, SQ | 1 |
Berner, PA; Eifel, PJ; Gonzalez, GM; Kisling, KD; Klopp, AH; Mikell, JK; Mourtada, F; Price, MJ | 1 |
Chanchien, CC; Huang, EY; Huang, YJ; Lan, JH; Lin, H; Sun, LM; Wang, CJ; Wang, CY | 1 |
Geli, E; Gkeli, MG; Koukourakis, GV; Miliadou, A; Sotiropoulou-Lontou, A; Tsalafoutas, I | 1 |
Cho, NH; Kim, GE; Kim, S; Kim, SW; Kim, YB; Kim, YT; Koom, WS; Nam, EJ | 1 |
Dally, M; de la Torre, M; Kizilbash, N; Kurusun, S; Levin, V; Nag, S; Pinillos, L; Pokrajac, B; Sur, R; Tatsuzaki, H | 1 |
Inoue, T; Nakamura, S; Oh, RJ; Shimamoto, S; Shiomi, H; Tanaka, E; Teshima, T; Yamada, Y | 1 |
Charoonsantikul, C; Chottetanaprasith, T; Jumpangern, C; Khorprasert, C; Lertbutsayanukul, C; Lertsanguansinchai, P; Rojpornpradit, P; Shotelersuk, K; Srisuthep, A; Suriyapee, S; Tresukosol, D | 1 |
Chen, SW; Liang, JA; Lin, FJ; Shiau, AC; Yang, SN; Yeh, LS | 1 |
Chang, HJ; Cheng, SH; Chung, YL; Horng, CF; Hsieh, CI; Hung, CF; Jian, JJ; Soong, T; Tan, TD; Tsou, MH | 1 |
Berghold, A; Kapp, DS; Kapp, KS; Lahousen, M; Oechs, A; Petru, E; Poschauko, J; Tauss, J; Winter, R | 1 |
Chie, EK; Cho, JK; Cho, KH; Kim, DY; Kim, JY; Kim, TH; Park, SY; Pyo, HR; Shin, KH | 1 |
Füller, J; Hinkelbein, W; Köhler, C; Marnitz, S; Schneider, A | 1 |
Briot, E; De Brabandere, M; Dimopoulos, J; Dumas, I; Georg, D; Haie-Meder, C; Kirisits, C; Lang, S; Nulens, A; Petrow, P; Pötter, R; Van Limbergen, E | 1 |
Inoue, T; Oh, RJ; Suzuki, O; Takeda, T; Tanaka, E; Teshima, T | 1 |
Fijuth, J; Markowska, J; Pietraszek, A; Sobotkowski, J | 1 |
Inoue, T; Isohashi, F; Kawaguchi, Y; Konishi, K; Kotsuma, T; Morimoto, M; Nakamura, S; Shiomi, H; Suzuki, O; Yoshioka, Y | 1 |
Barker, A; Cheng, MC; Nair, MT; Rouse, BS | 1 |
Coen, V; Coghe, M; De Neve, W; Storme, G; Van den Heuvel, F; Verellen, D | 1 |
Denham, JW; Howlett, SJ; Kron, T | 1 |
Bouscale, D; Cansdale, J; Cook, M; Hoskin, PJ | 1 |
Hackl, A; Kapp, DS; Kapp, KS; Pickel, H; Poschauko, J; Stuecklschweiger, GF | 1 |
Iraha, S; Kakinohana, Y; Ogawa, K; Sawada, S; Toita, T; Yoshinaga, M; Zukeran, Y | 1 |
Hellebust, TP; Knutsen, BH; Olsen, DR; Skretting, A | 1 |
Kanaev, SV; Turkevich, VG | 1 |
Eich, HT; Haverkamp, U; Micke, O; Pötter, R; Prott, FJ | 1 |
Hackl, A; Kapp, DS; Kapp, KS; Lahousen, M; Pickel, H; Poschauko, J; Stuecklschweiger, GF | 1 |
Mar'ina, LA; Nechushkin, MI; Riabtseva, AM; Uĭmanov, VA | 1 |
Barth-Jones, DC; Edmundson, GK; Frazier, AJ; Gupta, AK; Gustafson, GS; Martinez, AA; Mele, E; Vicini, FA | 1 |
Bendre, DD; Demanes, DJ; Ewing, TL; Rodriguez, RR | 1 |
Harima, K; Harima, Y; Nagata, K; Ohnishi, T; Oka, A; Ostapenko, VV; Shikata, N; Tanaka, Y | 1 |
Elders, LH; Hoekstra, CJ; Koster, K; Kuipers, T; Mak, AC; Pop, LA; van 't Riet, A; Vonk, EJ | 1 |
Fellner, C; Knocke, TH; Pötter, R; Wambersie, A | 1 |
Albano, K; Decker, WE; Erickson, B; Gillin, M | 1 |
Agarwal, JP; Budrukkar, AN; Deshpande, DD; Dinshaw, KA; Jalali, R; Nehru, RM; Shrivastava, SK | 1 |
Costanzo, S; Ferraris, R; Gola, M; Sinistrero, G; Sismondi, P | 1 |
Hackl, AG; Kapp, DS; Kapp, KS; Stuecklschweiger, GF | 1 |
Buchler, DA; Fowler, JF; Kinsella, TJ; Paliwal, BR; Shahabi, S; Stitt, JA; Thomadsen, BR | 1 |
Buchler, DA; Fowler, JF; Kinsella, TJ; Paliwal, BP; Stitt, JA; Thomadsen, BR | 1 |
Arian-Schad, KS; Hackl, A; Poier, E; Poschauko, J; Stuecklschweiger, GF | 1 |
Arian-Schad, K; Ebner, F; Einspieler, R; Flückiger, F; Hausegger, K; Poschauko, H | 1 |
Anania, C; Cilento, N; Maffei, G; Prato, R; Romeo, F; Scoppa, GF | 1 |
Atzinger, A; Breit, A; Wagner, RK | 1 |
Busch, M; Dühmke, E | 1 |
Günther, R; Kloetzer, KH; Kob, D; Walter, W | 1 |
Fietkau, R; Herbst, M; Müller, RG; Müller, W; Puthawala, A; Sauer, R; Stauner, J; Thiel, HJ | 1 |
Glaser, FH | 1 |
Crook, J; Marinello, G; Mege, JP; Pierquin, B | 1 |
10 trial(s) available for iridium radioisotopes and Cancer of Cervix
Article | Year |
---|---|
[Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Staging; Paclitaxel; Radioisotope Teletherapy; Survival Rate; Uterine Cervical Neoplasms | 2008 |
[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma].
Topics: Brachytherapy; Carcinoma; Cesium Radioisotopes; Costs and Cost Analysis; Dose Fractionation, Radiation; Female; Humans; Insurance, Health, Reimbursement; Iridium Radioisotopes; Prospective Studies; Radiometry; Radiotherapy Dosage; Therapies, Investigational; Uterine Cervical Neoplasms | 2010 |
[A randomized controlled trial of two chemotherapy regimens (paclitaxel liposome combined with platinum and paclitaxel combined with platinum) in concurrent chemoradiotherapy for cervical carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Cobalt Radioisotopes; Exanthema; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Iridium Radioisotopes; Liposomes; Middle Aged; Neoplasm Staging; Paclitaxel; Remission Induction; Survival Rate; Uterine Cervical Neoplasms | 2011 |
[Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Diarrhea; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Leukopenia; Megestrol; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Particle Accelerators; Radiotherapy, High-Energy; Remission Induction; Survival Rate; Thrombocytopenia; Uterine Cervical Neoplasms | 2011 |
Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Cesium Radioisotopes; Disease-Free Survival; Female; Humans; Iridium Radioisotopes; Japan; Middle Aged; Neoplasm Staging; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms; Uterine Neoplasms | 2003 |
Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Topics: Adult; Aged; Brachytherapy; Cesium Radioisotopes; Female; Humans; Intestine, Small; Iridium Radioisotopes; Middle Aged; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Rectum; Survival Rate; Treatment Failure; Urinary Bladder; Uterine Cervical Neoplasms | 2004 |
Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Topics: Adult; Aged; Antineoplastic Agents; Brachytherapy; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Radiation; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Iridium Radioisotopes; Middle Aged; Prospective Studies; Radiotherapy; Treatment Outcome; Uterine Cervical Neoplasms | 2005 |
Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations.
Topics: Brachytherapy; Carcinoma; Cesium Radioisotopes; Colon, Sigmoid; Dose Fractionation, Radiation; Feasibility Studies; Female; Guideline Adherence; Humans; Iridium Radioisotopes; Magnetic Resonance Imaging; Neoplasm Staging; Practice Guidelines as Topic; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Rectum; Relative Biological Effectiveness; Tomography, X-Ray Computed; Urinary Bladder; Uterine Cervical Neoplasms | 2006 |
Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma.
Topics: Aged; Apoptosis; bcl-2-Associated X Protein; Brachytherapy; Female; Gene Expression Regulation, Neoplastic; Humans; Hyperthermia, Induced; Immunohistochemistry; Iridium Radioisotopes; Middle Aged; Neoplasm Staging; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiotherapy Dosage; Treatment Outcome; Uterine Cervical Neoplasms | 2000 |
HDR brachytherapy applied to cervical carcinoma with moderate lateral expansion: modified principles of treatment.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Dose-Response Relationship, Drug; Female; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Osteonecrosis; Proctocolitis; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Uterine Cervical Neoplasms | 2001 |
83 other study(ies) available for iridium radioisotopes and Cancer of Cervix
Article | Year |
---|---|
Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma Uterine Cervix.
Topics: Brachytherapy; Carcinoma; Cobalt Radioisotopes; Female; Humans; Iridium Radioisotopes; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2022 |
Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer.
Topics: Brachytherapy; Cobalt Radioisotopes; Female; Humans; Iridium Radioisotopes; Organs at Risk; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Uterine Cervical Neoplasms | 2022 |
High-dose-rate intracavitary brachytherapy for recurrent cervical cancer in the vaginal stump after hysterectomy.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Disease-Free Survival; Female; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms; Vagina | 2019 |
Methodology of dose calculation for external beam radiation combined with high dose rate brachytherapy in the era of 3-dimensional treatment planning system.
Topics: Algorithms; Brachytherapy; Carcinoma; Dose Fractionation, Radiation; Female; Humans; Iridium Radioisotopes; Male; Nasopharyngeal Neoplasms; Prostatic Neoplasms; Radiation Dosage; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2020 |
Impact of radiation source activity on short- and long-term outcomes of cervical carcinoma patients treated with high-dose-rate brachytherapy: A retrospective cohort study.
Topics: Brachytherapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Female; Humans; Iridium Radioisotopes; Neoplasm Recurrence, Local; Retrospective Studies; Uterine Cervical Neoplasms | 2020 |
On the impact of absorbed dose specification, tissue heterogeneities, and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75, and Yb-169 in conventional and intensity-modulated brachytherapy for the treatment of cervical cancer.
Topics: Brachytherapy; Female; Humans; Iridium Radioisotopes; Monte Carlo Method; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Uterine Cervical Neoplasms | 2021 |
Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Topics: Brachytherapy; Cobalt Radioisotopes; Female; Humans; Iridium Radioisotopes; Monte Carlo Method; Organs at Risk; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Uterine Cervical Neoplasms; Ytterbium | 2017 |
PROFICIENCY TEST OF THE SSDL-ININ-MEXICO FOR THE CALIBRATION OF WELL-TYPE CHAMBERS WITH HDR 192IR SOURCES USING TWO DIFFERENT DOSIMETRY CODES OF PRACTICE FOR THE DETERMINATION OF REFERENCE AIR KERMA RATE KR.
Topics: Brachytherapy; Calibration; Equipment Design; Female; Humans; Iridium Radioisotopes; Mexico; Radiation Dosimeters; Radiometry; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2018 |
Automated source tracking with a pinhole imaging system during high-dose-rate brachytherapy treatment.
Topics: Brachytherapy; Female; Humans; Image Processing, Computer-Assisted; Iridium Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Uterine Cervical Neoplasms | 2018 |
Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Cobalt Radioisotopes; Female; Humans; Iridium Radioisotopes; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiotherapy Dosage; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2018 |
Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Iridium Radioisotopes; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Risk; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
Monte Carlo dosimetry study of novel rotating MRI-compatible shielded tandems for intensity modulated cervix brachytherapy.
Topics: Anisotropy; Brachytherapy; Female; Humans; Iridium Radioisotopes; Magnetic Resonance Imaging; Monte Carlo Method; Radiometry; Radiotherapy, Intensity-Modulated; Selenium Radioisotopes; Uterine Cervical Neoplasms; Ytterbium | 2020 |
RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning.
Topics: Brachytherapy; Colon, Sigmoid; Deep Learning; Female; Humans; Iridium Radioisotopes; Male; Monte Carlo Method; Neural Networks, Computer; Organs at Risk; Prostate; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Retrospective Studies; Urinary Bladder; Uterine Cervical Neoplasms | 2020 |
A multicentre audit of HDR/PDR brachytherapy absolute dosimetry in association with the INTERLACE trial (NCT015662405).
Topics: Algorithms; Brachytherapy; Catheters; Clinical Audit; Clinical Trials, Phase III as Topic; Female; Humans; Iridium Radioisotopes; Phantoms, Imaging; Radiation Dosage; Radiometry; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2017 |
Direct reconstruction and associated uncertainties of 192Ir source dwell positions in ring applicators using gafchromic film in the treatment planning of HDR brachytherapy cervix patients.
Topics: Brachytherapy; Female; Film Dosimetry; Humans; Imaging, Three-Dimensional; Iridium Radioisotopes; Radiation Dosage; Radionuclide Imaging; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Uncertainty; Uterine Cervical Neoplasms | 2013 |
[Comparison of the efficacy of three neoadjuvant therapy regimens on locally advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Female; Humans; Hysterectomy; Iridium Radioisotopes; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Preoperative Period; Radiotherapy, Adjuvant; Retrospective Studies; Serpins; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Apolipoprotein C-II is a potential serum biomarker as a prognostic factor of locally advanced cervical cancer after chemoradiation therapy.
Topics: Apolipoprotein C-II; Biomarkers, Tumor; Brachytherapy; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Female; Humans; Iridium Radioisotopes; Nephelometry and Turbidimetry; Peptide Mapping; Prognosis; Protein Array Analysis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Statistics, Nonparametric; Tandem Mass Spectrometry; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
Topics: Adult; Algorithms; Brachytherapy; Colon, Sigmoid; Equipment Design; Female; Humans; Iridium Radioisotopes; Magnetic Resonance Imaging; Middle Aged; Monte Carlo Method; Organs at Risk; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Tungsten; Urinary Bladder; Uterine Cervical Neoplasms; Young Adult | 2014 |
HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators.
Topics: Algorithms; Brachytherapy; Calibration; Esophageal Neoplasms; Female; Humans; Iridium Radioisotopes; Models, Biological; Monte Carlo Method; Photons; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Spinal Cord; Uterine Cervical Neoplasms; Water | 2014 |
Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Constriction, Pathologic; Female; Humans; Iridium Radioisotopes; Middle Aged; Pallor; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Vaginal Diseases | 2015 |
Comparison of Axxent-Xoft, (192)Ir and (60)Co high-dose-rate brachytherapy sources for image-guided brachytherapy treatment planning for cervical cancer.
Topics: Brachytherapy; Cobalt Radioisotopes; Female; Humans; Iridium Radioisotopes; Organ Sparing Treatments; Organs at Risk; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Rectum; Retrospective Studies; Urinary Bladder; Uterine Cervical Neoplasms | 2015 |
Effect of rectal enemas on rectal dosimetric parameters during high-dose-rate vaginal cuff brachytherapy: A prospective trial.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Endometrial Neoplasms; Enema; Female; Humans; Imaging, Three-Dimensional; Iridium Radioisotopes; Middle Aged; Neoplasm Staging; Organ Size; Prospective Studies; Radiometry; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rectum; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2016 |
High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Radiotherapy; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Middle Aged; Radiation Injuries; Radiotherapy Dosage; Rectum; Reference Values; Regression Analysis; Risk Factors; Urinary Bladder; Uterine Cervical Neoplasms | 2009 |
[Quality control in pulsed dose rate brachytherapy].
Topics: Autoradiography; Brachytherapy; Female; France; Humans; Iridium Radioisotopes; Program Evaluation; Prospective Studies; Quality Control; Radiation Protection; Uterine Cervical Neoplasms | 2009 |
Factors for predicting rectal dose of high-dose-rate intracavitary brachytherapy after pelvic irradiation in patients with cervical cancer: a retrospective study with radiography-based dosimetry.
Topics: Adenocarcinoma; Brachytherapy; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Middle Aged; Proctitis; Radiation Injuries; Radiography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Rectum; Regression Analysis; Relative Biological Effectiveness; Retrospective Studies; Uterine Cervical Neoplasms | 2010 |
Optimisation techniques in vaginal cuff brachytherapy.
Topics: Brachytherapy; Endometrial Neoplasms; Female; Humans; Iridium Radioisotopes; Prospective Studies; Radiotherapy Dosage; Uterine Cervical Neoplasms; Vagina | 2009 |
Does the entire uterus need to be treated in cancer of the cervix? Role of adaptive brachytherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Neoplasm Recurrence, Local; Rectum; Retrospective Studies; Urinary Bladder; Uterine Cervical Neoplasms; Uterine Neoplasms; Vagina | 2010 |
Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
Topics: Brachytherapy; Colon, Sigmoid; Dose Fractionation, Radiation; Equipment Design; Female; Humans; Intestine, Small; Iridium Radioisotopes; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Rectum; Tomography, X-Ray Computed; Tumor Burden; Urinary Bladder; Uterine Cervical Neoplasms | 2009 |
[Comparison of uterine artery chemoembolization and internal iliac arterial infusion chemotherapy for the combining treatment for women with locally advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Iliac Artery; Infusions, Intra-Arterial; Iridium Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Remission Induction; Retrospective Studies; Tumor Burden; Uterine Artery; Uterine Cervical Neoplasms; Young Adult | 2009 |
Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Agents; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Iridium Radioisotopes; Japan; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms | 2009 |
Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer.
Topics: Brachytherapy; Computer Simulation; Equipment Design; Female; Film Dosimetry; Humans; Iridium Radioisotopes; Models, Theoretical; Monte Carlo Method; Phantoms, Imaging; Radiation Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Rotation; Tomography, X-Ray Computed; Uncertainty; Urinary Bladder; Uterine Cervical Neoplasms | 2009 |
Rectal dose and source strength of the high-dose-rate iridium-192 both affect late rectal bleeding after intracavitary radiation therapy for uterine cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Iridium Radioisotopes; Middle Aged; Radiation Injuries; Rectal Diseases; Rectum; Relative Biological Effectiveness; Uterine Cervical Neoplasms | 2010 |
Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy.
Topics: Brachytherapy; Computer Simulation; Feasibility Studies; Female; Fiber Optic Technology; Humans; Iridium Radioisotopes; Luminescence; Needles; Practice Guidelines as Topic; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Stainless Steel; Time Factors; Titanium; Uncertainty; Uterine Cervical Neoplasms | 2009 |
Dose perturbation due to the polysulfone cap surrounding a Fletcher-Williamson colpostat.
Topics: Algorithms; Brachytherapy; Female; Humans; Iridium Radioisotopes; Monte Carlo Method; Mucous Membrane; Polymers; Protective Devices; Radiometry; Radiotherapy Dosage; Rectum; Relative Biological Effectiveness; Sulfones; Tungsten; Urinary Bladder; Uterine Cervical Neoplasms; Vagina | 2010 |
[Surgical intervention for the central recurrence or persistent local lesion of uterine cervical carcinoma following full-dose radiotherapy].
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Cervix Uteri; Cesium Radioisotopes; Female; Follow-Up Studies; Humans; Hysterectomy; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms; Young Adult | 2010 |
Lack of the dose-rate effect of 192Ir source activity on pelvic control and late complications after high-dose-rate brachytherapy for cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brachytherapy; Carcinoma; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Female; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Pelvic Neoplasms; Radiation Injuries; Radiotherapy Dosage; Rectal Diseases; Risk Factors; Urinary Bladder Diseases; Uterine Cervical Neoplasms | 2010 |
CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Humans; Imaging, Three-Dimensional; Iridium Radioisotopes; Middle Aged; Organ Size; Radiation Injuries; Radiation Protection; Radiometry; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Diseases; Rectum; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Dose reduction study in vaginal balloon packing filled with contrast for HDR brachytherapy treatment.
Topics: Air; Brachytherapy; Contrast Media; Dilatation; Female; Gadolinium DTPA; Humans; Iodine; Iridium Radioisotopes; Monte Carlo Method; Organometallic Compounds; Organs at Risk; Phantoms, Imaging; Radiation Injuries; Radiation Protection; Radiotherapy Dosage; Rectum; Sodium Chloride; Triiodobenzoic Acids; Urinary Bladder; Uterine Cervical Neoplasms; Vagina; Water | 2011 |
Radiosensitization of human cervical cancer cells by inhibiting ribonucleotide reductase: enhanced radiation response at low-dose rates.
Topics: Cell Cycle; Cell Line, Tumor; Enzyme Inhibitors; Female; Flow Cytometry; G1 Phase; Humans; Iridium Radioisotopes; Neoplasm Proteins; Pyridines; Radiation Dosage; Radiation Tolerance; Radiotherapy; Ribonucleotide Reductases; Thiosemicarbazones; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 2011 |
Evaluation of linear array MOSFET detectors for in vivo dosimetry to measure rectal dose in HDR brachytherapy.
Topics: Body Burden; Brachytherapy; Calibration; Equipment Design; Feasibility Studies; Female; Humans; Iridium Radioisotopes; Male; Prostatic Neoplasms; Quality Assurance, Health Care; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Reproducibility of Results; Transistors, Electronic; Uterine Cervical Neoplasms | 2011 |
Patterns of radiotherapy practice for patients with cervical cancer in Japan, 2003-2005: changing trends in the pattern of care process.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Chemoradiotherapy; Chemotherapy, Adjuvant; Female; Health Care Surveys; Humans; Iridium Radioisotopes; Japan; Middle Aged; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2012 |
Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy.
Topics: Bone and Bones; Brachytherapy; Cohort Studies; Colon, Sigmoid; Female; Humans; Iridium Radioisotopes; Muscles; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Retrospective Studies; Software; Urinary Bladder; Urinary Catheterization; Uterine Cervical Neoplasms | 2012 |
A prospective cohort study to compare treatment results between 2 fractionation schedules of high-dose-rate intracavitary brachytherapy (HDR-ICBT) in patients with cervical cancer.
Topics: Age Factors; Aged; Brachytherapy; Cystitis; Dose Fractionation, Radiation; Enterocolitis; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Middle Aged; Proctitis; Prospective Studies; Radiation Injuries; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Ultrasound-assisted endocavitary HDR-Ir(192) brachytherapy for unresectable locally advanced uterine cervix carcinoma: retrospective analysis focusing the efficacy and tolerability.
Topics: Adult; Aged; Brachytherapy; Carcinoma; Disease-Free Survival; Female; Humans; Iridium Radioisotopes; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Retrospective Studies; Ultrasonography; Uterine Cervical Neoplasms | 2013 |
High-dose-rate intracavitary radiotherapy in the management of cervical intraepithelial neoplasia 3 and carcinoma in situ presenting with poor histologic factors after undergoing excisional procedures.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma in Situ; Cervix Uteri; Cobalt Radioisotopes; Disease-Free Survival; Female; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm, Residual; Postoperative Care; Radiotherapy Dosage; Retrospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2012 |
Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency.
Topics: Brachytherapy; Cobalt Radioisotopes; Costs and Cost Analysis; Developing Countries; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Health Plan Implementation; Humans; International Agencies; Iridium Radioisotopes; Lung Neoplasms; Male; Nuclear Energy; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2002 |
Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Topics: Adenocarcinoma; Brachytherapy; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Humans; Iridium Radioisotopes; Logistic Models; Radiation Injuries; Radiotherapy Dosage; Rectum; Survival Analysis; Time Factors; Urinary Bladder; Uterine Cervical Neoplasms | 2004 |
Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anemia; Carcinoma, Squamous Cell; Disease-Free Survival; Embolization, Therapeutic; Erythrocyte Transfusion; Female; Humans; Iridium Radioisotopes; Middle Aged; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Hemorrhage | 2005 |
CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
Topics: Antineoplastic Agents; Brachytherapy; Cisplatin; Female; Humans; Iridium Radioisotopes; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Tomography, X-Ray Computed; Urinary Bladder; Uterine Cervical Neoplasms | 2006 |
Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer.
Topics: Adult; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Cervix Uteri; Cisplatin; Combined Modality Therapy; Female; Humans; Hysterectomy; Iridium Radioisotopes; Laparoscopy; Middle Aged; Necrosis; Neoplasm Staging; Ovariectomy; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Conformal; Time Factors; Uterine Cervical Neoplasms; Uterus | 2006 |
Intracavitary brachytherapy for carcinoma of the uterine cervix--comparison of HDR (Ir-192) and MDR (Cs-137).
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Cesium Radioisotopes; Chi-Square Distribution; Female; Humans; Iridium Radioisotopes; Middle Aged; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
Preliminary results of mitomycin C local application as post-treatment prevention of vaginal radiation-induced morbidity in women with cervical cancer.
Topics: Antibiotics, Antineoplastic; Brachytherapy; Female; Humans; Iridium Radioisotopes; Middle Aged; Mitomycin; Morbidity; Radiation Injuries; Uterine Cervical Neoplasms; Vaginal Diseases | 2006 |
Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Chi-Square Distribution; Female; Gastrointestinal Hemorrhage; Humans; Iridium Radioisotopes; Middle Aged; Radiation Injuries; Radiotherapy Dosage; Rectum; Relative Biological Effectiveness; Retrospective Studies; Uterine Cervical Neoplasms | 2008 |
High dose rate (HDR) brachytherapy technique: for carcinoma of uterine cervix using Nucletron applicators.
Topics: Brachytherapy; Equipment Design; Female; Humans; Iridium Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, High-Energy; Rectum; Urinary Bladder; Uterine Cervical Neoplasms | 1995 |
On the determination of the effective transmission factor for stainless steel ovoid shielding segments and estimation of their shielding efficacy for the clinical situation.
Topics: Biophysical Phenomena; Biophysics; Brachytherapy; Female; Humans; Iridium Radioisotopes; Radiation Protection; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Stainless Steel; Uterine Cervical Neoplasms | 1994 |
Evaluation of rectal shielding in a Henschke system applicator.
Topics: Brachytherapy; Female; Humans; Iridium Radioisotopes; Radiotherapy Dosage; Rectum; Uterine Cervical Neoplasms | 1996 |
Changes in applicator position with fractionated high dose rate gynaecological brachytherapy.
Topics: Brachytherapy; Endometrial Neoplasms; Female; Humans; Iridium Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Uterine Cervical Neoplasms | 1996 |
Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy.
Topics: Brachytherapy; Carcinoma; Female; Genitalia, Female; Humans; Iridium Radioisotopes; Radiation Dosage; Radiation Injuries; Rectum; Urinary Tract; Uterine Cervical Neoplasms | 1997 |
[Comparison of calculated and measured rectal doses in HDR brachytherapy with Ir-192 source].
Topics: Brachytherapy; Female; Humans; Iridium Radioisotopes; Mathematics; Phantoms, Imaging; Radiometry; Radiotherapy Dosage; Rectum; Sensitivity and Specificity; Uterine Cervical Neoplasms | 1997 |
Determination of 3D dose distribution from intracavitary brachytherapy of cervical cancer by MRI of irradiated ferrous sulphate gel.
Topics: Brachytherapy; Female; Ferrous Compounds; Gels; Humans; Iridium Radioisotopes; Magnetic Resonance Imaging; Phantoms, Imaging; Radiotherapy Dosage; Uterine Cervical Neoplasms | 1997 |
[Current techniques of brachytherapy in primary and metastatic cancers of the vagina].
Topics: Brachytherapy; Cesium Radioisotopes; Endometrial Neoplasms; Female; Humans; Iridium Radioisotopes; Neoplasm Staging; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms | 1997 |
[Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma].
Topics: Brachytherapy; Computer Graphics; Female; Humans; Iridium Radioisotopes; Lymphatic Irradiation; Prospective Studies; Quality Assurance, Health Care; Radiation Injuries; Radiation Monitoring; Radiotherapy Planning, Computer-Assisted; Radiotherapy, High-Energy; Rectum; Reference Values; Retrospective Studies; Uterine Cervical Neoplasms | 1998 |
Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Brachytherapy; Carcinoma; Disease-Free Survival; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Prognosis; Radiopharmaceuticals; Treatment Outcome; Uterine Cervical Neoplasms | 1998 |
[Interstitial gamma therapy using automated remote-control positioning of radiation sources in the treatment of malignant vaginal and vulvar neoplasms].
Topics: Adult; Aged; Brachytherapy; Cesium Radioisotopes; Cobalt Radioisotopes; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Radiotherapy, Computer-Assisted; Time Factors; Uterine Cervical Neoplasms; Uterine Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 1998 |
Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Brachytherapy; Female; Genital Neoplasms, Female; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Urethral Neoplasms; Uterine Cervical Neoplasms; Vaginal Neoplasms | 1999 |
High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Humans; Iridium Radioisotopes; Middle Aged; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Uterine Cervical Neoplasms | 1999 |
Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects.
Topics: Brachytherapy; Carcinoma; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Humans; Iridium Radioisotopes; Neoplasm Recurrence, Local; Quality Assurance, Health Care; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2001 |
Comparison of traditional low-dose-rate to optimized and nonoptimized high-dose-rate tandem and ovoid dosimetry.
Topics: Brachytherapy; Dose-Response Relationship, Radiation; Female; Humans; Iridium Radioisotopes; Radiotherapy Planning, Computer-Assisted; Uterine Cervical Neoplasms | 2001 |
Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Brachytherapy; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Disease-Free Survival; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Middle Aged; Particle Accelerators; Prognosis; Radiotherapy Dosage; Survival Analysis; Time Factors; Uterine Cervical Neoplasms | 2001 |
[Endocavitary radiotherapy of carcinoma of the cervix uteri using a modeled device and Ir-192. Computerized dosimetry].
Topics: Adult; Aged; Brachytherapy; Female; Humans; Iridium Radioisotopes; Radiotherapy Dosage; Radiotherapy, Computer-Assisted; Uterine Cervical Neoplasms | 1976 |
Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques.
Topics: Brachytherapy; Endometrial Neoplasms; Female; Film Dosimetry; Humans; Iridium Radioisotopes; Middle Aged; Radiation Dosage; Radiotherapy Dosage; Rectum; Thermoluminescent Dosimetry; Tomography, X-Ray Computed; Urinary Bladder; Uterine Cervical Neoplasms | 1992 |
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations.
Topics: Brachytherapy; Female; Humans; Iridium Radioisotopes; Quality Assurance, Health Care; Radiotherapy Dosage; Uterine Cervical Neoplasms | 1992 |
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations.
Topics: Brachytherapy; Cell Survival; Female; Humans; Iridium Radioisotopes; Radiotherapy Dosage; Relative Biological Effectiveness; Uterine Cervical Neoplasms | 1992 |
Bladder and rectal dose of gynecologic high-dose-rate implants: comparison of orthogonal radiographic measurements with in vivo and CT-assisted measurements.
Topics: Brachytherapy; Endometrial Neoplasms; Female; Humans; Iridium Radioisotopes; Radiotherapy Dosage; Rectum; Retrospective Studies; Thermoluminescent Dosimetry; Tomography, X-Ray Computed; Urinary Bladder; Uterine Cervical Neoplasms | 1991 |
[Value of magnetic resonance tomography after primary irradiation of carcinoma of the cervix uteri: evaluation of therapeutic success and follow-up].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Magnetic Resonance Imaging; Middle Aged; Radiotherapy Dosage; Time Factors; Uterine Cervical Neoplasms | 1991 |
Combined curietherapy and surgery in management of stage II.B cervical carcinoma.
Topics: Brachytherapy; Female; Humans; Hysterectomy; Iridium Radioisotopes; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms | 1990 |
[The monitoring of gynecological radiotherapy using serial tumor marker determinations].
Topics: Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Middle Aged; Radiotherapy Dosage; Sensitivity and Specificity; Serpins; Uterine Cervical Neoplasms; Uterine Neoplasms | 1990 |
Optimized afterloading therapy of cervix carcinoma with the discontinuous movement of the iridium source.
Topics: Brachytherapy; Female; Humans; Iridium Radioisotopes; Radiotherapy Planning, Computer-Assisted; Uterine Cervical Neoplasms | 1990 |
[Shielded vaginal applicators for line-shaped 192Ir sources for use in the irradiation of cervix cancer].
Topics: Brachytherapy; Female; Humans; Iridium Radioisotopes; Radiation Protection; Uterine Cervical Neoplasms | 1990 |
[A new multi-channel LDR/MDR-afterloading-system (Inter-Pal-C38)].
Topics: Anus Neoplasms; Brachytherapy; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Iridium Radioisotopes; Radiation Protection; Radiotherapy, Computer-Assisted; Uterine Cervical Neoplasms | 1989 |
Comparison of HDR afterloading with 192Ir versus conventional radium therapy in cervix cancer: 5-year results and complications.
Topics: Brachytherapy; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Radium; Uterine Cervical Neoplasms | 1988 |
Intracavitary irradiation of carcinomas of the uterus and cervix: the Créteil method.
Topics: Brachytherapy; Female; Humans; Iridium Radioisotopes; Uterine Cervical Neoplasms; Uterine Neoplasms | 1988 |